Low riskFDA DrugClass III

Ascend dabigatran capsules recalled for failed impurity specifications

Ascend Laboratories is recalling dabigatran etexilate capsules, 110 mg, after an out-of-specification result in 12-month long-term stability testing for Impurity II, Impurity III and total impurities. This means the product failed its impurity specifications. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Ascend Laboratories recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check whether your carton is a 60-count carton with NDC 0904-7254-68 and lot 25141707, expiration 4/30/2027.
  3. The notice doesn't say how to get a refund or replacement; contact Ascend Laboratories or the pharmacy where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7254-68.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
1,753 cartons
Illnesses reported
None reported
Manufactured in
135 Us Highway 202 206 Ste 15, N/A, Bedminster, NJ, United States
Classification
Class III
Recall number
D-0735-2026

In the FDA's words

Description
Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7254-68. Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability. Lot: 25141707, Exp 4/30/2027. Distribution: USA Nationwide Affected quantity: 1,753 cartons
Hazard
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

2 products in this recall

The agency lists each product separately. Check every one you might have.

More from Ascend Laboratories

See all

Related topics

Industrial chemicalsOtherDrugsSold nationwideMore from FDA Drug